文献速递膀胱癌与上尿路尿路上皮癌前列腺增生与排尿功能障碍

根治性膀胱切除术后男性原位新膀胱患者需导尿及尿潴留的预测因素

Predictors of need for catheterisation and urinary retention after radical cystectomy and orthotopic neobladder in male patients.
PubMed 文献 · BJU Int · 2021-01-20

该研究基于299例连续男性膀胱癌患者的前瞻性数据库,在术后门诊随访时通过改道相关问卷收集信息,定义尿潴留为每日≥3次导尿或自述无法自行排尿。多变量Cox回归显示BMI≥27 kg/m2显著增加导尿需求及尿潴留风险。

要点

  • BMI≥27 kg/m2显著增加导尿需求(HR 2.34)及尿潴留风险(HR 5.20)。
  • Charlson合并症指数评分≥2与任何导尿需求相关(HR 1.84),但与尿潴留无关。
  • 病理分期和改道类型不是导尿需求或尿潴留的显著预测因素。

核心结论

  • 男性根治性膀胱切除加原位新膀胱患者中,需要导尿才能排尿的尿潴留不常见。
  • BMI≥27 kg/m2的患者尿潴留及需自行导尿风险显著增加。

研究设计与样本

  • 基于机构审查委员会批准的前瞻性膀胱癌数据库,纳入299例连续男性膀胱癌患者,术后门诊随访时使用改道相关问卷收集信息。

主要发现

  • 51例(17%)报告自行导尿,其中22例(占总患者7.4%)存在尿潴留。
  • 术后3、5、10年免于任何导尿的比例分别为85%、77%、62%。
  • 术后3、5、10年免于尿潴留的比例分别为93%、88%、79%。
  • 多变量Cox回归显示BMI≥27 kg/m2显著增加导尿需求(HR 2.34,95%CI 1.26-4.32)及尿潴留风险(HR 5.20,95%CI 1.74-15.51)。
  • Charlson合并症指数评分≥2与任何导尿需求相关(HR 1.84,95%CI 1.02-3.3),但与尿潴留无关。

关键数值与推荐

  • 尿潴留定义为每日≥3次导尿或自述无法自行排尿。
  • BMI≥27 kg/m2为导尿需求及尿潴留的显著预测因素。
  • Charlson合并症指数评分≥2为任何导尿需求的预测因素。

临床怎么用

  • 对接受根治性膀胱切除加原位新膀胱的男性患者,术前应评估BMI和合并症以识别导尿及尿潴留高风险者。
  • BMI≥27 kg/m2的患者术后需加强排尿功能监测和患者教育。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate the prevalence of catheterisation and urinary retention in male patients with bladder cancer after radical cystectomy (RC) and orthotopic neobladder (ONB) and to identify potential predictors. PATIENTS AND METHODS: Using an Institutional Review Board approved, prospectively maintained bladder cancer database, we collected information using a diversion-related questionnaire from 299 consecutive male patients with bladder cancer upon postoperative clinic visit. Urinary retention was defined as ≥3 catheterisations/day or a self-reported inability to void without a catheter. Uni- and multivariable Cox regression analysis was performed to identify predictors of catheterisation and urinary retention. RESULTS: Self-catheterisation was reported in 51 patients (17%), of whom, 22 (7.4% of the total patients) were in retention. Freedom from any catheterisation at 3, 5, and 10 years after RC was 85%, 77%, and 62%, respectively. Freedom from retention at 3, 5, and 10 years after RC was 93%, 88%, and 79%, respectively. Multivariable Cox regression showed that higher body mass index (BMI; ≥27 kg/m2 ) significantly increased the need for catheterisation (hazard ratio [HR] 2.34, 95% confidence interval [CI] 1.26-4.32) as well as retention (HR 5.20, 95% CI 1.74-15.51). Greater medical comorbidity (Charlson Comorbidity Index score ≥2) correlated with the need for any catheterisation (HR 1.84, 95% CI 1.02-3.3), but not retention. Pathological stage and type of diversion were not significant predictors of the need to catheterise or urinary retention. CONCLUSION: In males undergoing RC with ONB, retention requiring catheterisation to void is uncommon. Patients with a BMI of ≥27 kg/m2 are at significantly increased risk of retention and need for self-catheterisation.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Ghodoussipour S, Ladi Seyedian SS, Jiang D, et al. Predictors of need for catheterisation and urinary retention after radical cystectomy and orthotopic neobladder in male patients. BJU Int. 2021. PMID: 33348465. doi:10.1111/bju.15329

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。